Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
83 results:

  • 1. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
    BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. erbb4-encoded novel miRNAs act as tumor suppressors by regulating ErbB/PI3K signaling.
    Ghaemi Z; Soltani BM; Mowla SJ
    Tumour Biol; 2022; 44(1):215-230. PubMed ID: 36442170
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
    Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
    Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The HER family as therapeutic targets in colorectal cancer.
    Ye P; Wang Y; Li R; Chen W; Wan L; Cai P
    Crit Rev Oncol Hematol; 2022 Jun; 174():103681. PubMed ID: 35462030
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnosis and Treatment of ERBB2-Positive Metastatic colorectal cancer: A Review.
    Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
    JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer.
    Elsayed I; Elsayed N; Feng Q; Sheahan K; Moran B; Wang X
    Cancer Biomark; 2022; 33(2):261-271. PubMed ID: 35213358
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients.
    Wills C; He Y; Summers MG; Lin Y; Phipps AI; Watts K; Law PJ; Al-Tassan NA; Maughan TS; Kaplan R; Houlston RS; Peters U; Newcomb PA; Chan AT; Buchanan DD; Gallinger S; Marchand LL; Pai RK; Shi Q; Alberts SR; Gray V; West HD; Escott-Price V; Dunlop MG; Cheadle JP
    Eur J Cancer; 2021 Dec; 159():247-258. PubMed ID: 34794066
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
    Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Validity of claims-based algorithms for selected cancers in Japan: Results from the VALIDATE-J study.
    de Luise C; Sugiyama N; Morishima T; Higuchi T; Katayama K; Nakamura S; Chen H; Nonnenmacher E; Hase R; Jinno S; Kinjo M; Suzuki D; Tanaka Y; Setoguchi S
    Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1153-1161. PubMed ID: 33960542
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Healthy lifestyles, genetic modifiers, and colorectal cancer risk: a prospective cohort study in the UK Biobank.
    Choi J; Jia G; Wen W; Shu XO; Zheng W
    Am J Clin Nutr; 2021 Apr; 113(4):810-820. PubMed ID: 33675346
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Löwenstein-Buschke: Clinicopathologic Analysis of 78 Cases of Large and Giant Condyloma Acuminata of the Anus.
    Taskin OC; Pehlivanoglu B; Reid MD; Friedman T; Lee M; Tadros TS; Bandyopadhyay S; Akinfolarin J; Armutlu A; Basturk O; Adsay V
    Turk Patoloji Derg; 2021; 37(1):18-25. PubMed ID: 33021736
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. her4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition.
    Jia X; Wang H; Li Z; Yan J; Guo Y; Zhao W; Gao L; Wang B; Jia Y
    Mol Med Rep; 2020 Apr; 21(4):1779-1788. PubMed ID: 32319604
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The role of erbb4 in cancer.
    Segers VFM; Dugaucquier L; Feyen E; Shakeri H; De Keulenaer GW
    Cell Oncol (Dordr); 2020 Jun; 43(3):335-352. PubMed ID: 32219702
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective.
    Cho J
    BMB Rep; 2020 Mar; 53(3):133-141. PubMed ID: 32172728
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
    Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
    Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic colorectal cancer.
    Duplaquet L; Figeac M; Leprêtre F; Frandemiche C; Villenet C; Sebda S; Sarafan-Vasseur N; Bénozène M; Vinchent A; Goormachtigh G; Wicquart L; Rousseau N; Beaussire L; Truant S; Michel P; Sabourin JC; Galateau-Sallé F; Copin MC; Zalcman G; De Launoit Y; Fafeur V; Tulasne D
    Mol Cancer Ther; 2019 Jun; 18(6):1137-1148. PubMed ID: 30926633
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
    Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
    Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.
    Millis SZ; Jardim DL; Albacker L; Ross JS; Miller VA; Ali SM; Kurzrock R
    Cancer; 2019 Apr; 125(7):1185-1199. PubMed ID: 30582752
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. erbb4 acts as a suppressor in colitis and its associated carcinoma by negatively regulating cholesterol metabolism.
    Ni H; Chen L; Song L; Sun L; Cui H; Zhou Q; Hu C; Jiao W; Shen T; Gao T; Liu Y; Li J
    Carcinogenesis; 2019 Jul; 40(5):680-686. PubMed ID: 30452622
    [TBL] [Abstract] [Full Text] [Related]  


    of 5.